All Activities

Examining the Evidence for Early Initiation of Disease-Modifying Therapy

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December...

Exploring the Use of Diagnostic Tools to Improve Early Detection of MS

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December...

Clinical Insights on When and How to Switch DMT in Patients With a Suboptimal Treatment Response

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December...

The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment – Jan. 19

Thursday, January 19, 2021 07:00 – 08:00 pm EST Learning...

Advancing the Role of the Nurse in the Management of MS in Rural Areas: An Online Curriculum

This online curriculum provides up-to-date information related to the comprehensive...

What Is Disease Modifying Therapy? Evidence-Based Disease Modification in Multiple Sclerosis

RELEASE DATE: December 30, 2020 VALID FOR CREDIT THROUGH: December...

IJMSC: “I Will Respect the Autonomy of My Patient”: A Scoping Review of Shared Decision Making in Multiple Sclerosis

Release Date: December 1, 2020 Valid for Credit Through: December...

The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment

RELEASE DATE: October 21, 2020 VALID FOR CREDIT THROUGH: October...

Cases in Multiple Sclerosis Treatment: Evidence-Based Approaches to Optimal Care

Released: November 13, 2020 Expires: November 13, 2021 Provided by...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Next-Generation S1P Modulators in MS Management

Released: October 30, 2020 Expires: October 30, 2021 Jointly Accredited...

Patient Considerations When Selecting Disease-Modifying Therapy in Multiple Sclerosis

RELEASE DATE: October 21, 2020 VALID FOR CREDIT THROUGH: October...

Differing Perspectives on Multiple Sclerosis Nursing Care

Release Date: October 20, 2020 Valid for Credit Through: October...

The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment

Release Date: July 31, 2020 Valid for Credit Through: July...

Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) — An ACTRIMS-ECTRIMS Virtual Satellite

Reshaping the Paradigm: Implications of Recent Clinical Advances in the...

IJMSC: Comparing Health Promotion and Quality of Life in People with Progressive Versus Nonprogressive Multiple Sclerosis

Release Date: October 1, 2020 Valid for Credit Through: October...

The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis

RELEASE DATE: October 1, 2020 EXPIRATION DATE: September 30, 2021 The...

Journal Club: Monoclonal Antibody Treatment during Pregnancy and/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder

Release Date: September 25, 2020 Valid for Credit Through: September...

Journal Club: The Dilemma of When to Stop Disease-Modifying Therapy in Multiple Sclerosis

Release Date: August 24, 2020 Valid for Credit Through: August...

IJMSC: Effects of Functional Electrical Stimulation Cycling on Fatigue and Quality of Life in People with Multiple Sclerosis Who Are Nonambulatory

RELEASE DATE: August 1, 2020 VALID FOR CREDIT THROUGH: August...

Telemedicine in the Era of COVID-19: Mitigating Risk for People Living with Multiple Sclerosis

RELEASE DATE: July 31, 2020 EXPIRATION DATE: July 31, 2021...

The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment

RELEASE DATE: July 31, 2020 EXPIRATION DATE: July 31, 2021...

Precision Medicine with Polypharmacy in Multiple Sclerosis: What does it mean in practice?

RELEASE DATE: July 15, 2020 EXPIRATION DATE: September 14, 2021 Precision Medicine...

Novel BTK Inhibitors: Effects on Adaptive and Innate Immunity in Multiple Sclerosis

RELEASE DATE: July 1, 2020 EXPIRATION DATE: June 30, 2021...

Everything You’ve Wanted to Know About MS But Were Afraid to Ask

RELEASE DATE: June 30, 2020 EXPIRATION DATE: June 30, 2021...

Advanced Therapeutic Strategies and Family Planning for Women with Multiple Sclerosis

RELEASE DATE: June 25, 2020 EXPIRATION DATE: June 24, 2021...

Journal Club: The COVID-19 Pandemic and the Use of MS Disease Modifying Therapies

Release Date: July 8, 2020 Valid for Credit Through: July...

A Virtual Reality View: Selecting Disease-Modifying Therapy for Multiple Sclerosis: Tools to Achieve and Maintain Control of a Dynamic Disease

RELEASE DATE: June 16, 2020 EXPIRATION DATE: June 16, 2021 FACULTY Patricia...

The Role of Neurologists and Neuroophthalmologists in the Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder

RELEASE DATE: June 16, 2020 EXPIRATION DATE: June 16, 2021 FACULTY Brian...

The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis

RELEASE DATE: June 1, 2020 EXPIRATION DATE: June 1, 2021 TARGET AUDIENCE...

IJMSC: Clinically Assessed Walking Capacity Versus Real-World Walking Performance in People with Multiple Sclerosis

RELEASE DATE: June 1, 2020 EXPIRATION DATE: June 1, 2021 TARGET AUDIENCEThe...

Right Patient, Right Treatment, Right Time: Utilizing Early, High-Efficacy Therapies to Improve Outcomes in RRMS

RELEASE DATE: June 8, 2020 EXPIRATION DATE: June 8, 2021...

A Clinician’s Guide to Cognition in MS

A Clinician’s Guide to Cognition in MSSarah Morrow, MD, MS,...

The Role of Biological Aging In MS Progression

The Role of Biological Aging In MS ProgressionJennifer Graves, MD,...

Use of Psychotropics in MS: Antidepressants, Antianxiety Agents, Mood Stabilizers, Hypnotics, Antipsychotics, and Cognitive Enhancers

Use of Psychotropics in MS: Antidepressants, Antianxiety Agents, Mood Stabilizers,...

Caring for Women across the Reproductive Lifespan

Caring for Women across the Reproductive LifespanRiley Bove, MD RELEASE...

The Role of Complement in MS

The Role of Complement in MSHorea Rus, MD, PhD RELEASE...

How Genes and Microbes Shape MS Risk

How Genes and Microbes Shape MS RiskSergio Baranzini, PhD RELEASE...

Cannabis and MS: Efficacy, Safety, Drug Interactions, and Research Update

Cannabis and MS: Efficacy, Safety, Drug Interactions, and Research UpdateAllen...

Emerging Therapies across the Disease Spectrum

Emerging Therapies across the Disease SpectrumBenjamin Greenberg, MD, MHS, CRND,...

Rehabilitation in MS: That was Then, This is Now

Rehabilitation in MS: That was Then, This is NowPatricia Bobryk,...

Current Perspectives of Pediatric Care and Research

Current Perspectives of Pediatric Care and ResearchBrenda Banwell, MD, FAAP,...

Importance of Assessing Nutritional Health in Patients with MS

Importance of Assessing Nutritional Health in Patients with MSMona Bostick,...

Depression and MS: Diagnosing and Treating

Depression and MS: Diagnosing and TreatingAnthony Feinstein, MPhil, PhD, FRCP...

Comorbidities and MS: Critical Thinking About DMTs and Vaccines

Comorbidities and MS: Critical Thinking About DMTs and VaccinesPatricia Melville,...

Whitaker Lecture: CNS Immune Responses that Underlie Progressive MS: Future Challenges in the COVID-19 Era

Whitaker Lecture: CNS Immune Responses that Underlie Progressive MS: Future...

Science, Art, and Practice of Behavioral Medicine

Science, Art, and Practice of Behavioral MedicineAmy Sullivan, PsyD, ABPP...

Neuromyelitis Optica Spectrum Disorders: Emerging Treatment Options

Neuromyelitis Optica Spectrum Disorders: Emerging Treatment OptionsBrian Weinshenker, MD RELEASE...

Progressive MS: Diagnosis, Clinical Course and Long-Term Management

Progressive MS: Diagnosis, Clinical Course and Long-Term ManagementPatricia K. Coyle,...

John F. Kurtzke Lecture: Stem Cell Research Update

John F. Kurtzke Lecture: Stem Cell Research UpdateMark Freedman, MSc,...

MS Infusion Therapy Update with Q&A on COVID-19 Impact

RELEASED: March 23, 2020 EXPIRES: April 30, 2021 Faculty Carrie...

IJMSC: Prevalence of Lower Urinary Tract Symptoms in People with MS: A Systematic Review and Meta-analysis

Release Date: April 1, 2020 Valid for Credit Through: April...

Journal Club: A 30–Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes

Release Date: February 24, 2020Valid for Credit Through: February 28,...

The Art of Multiple Sclerosis Therapies: Applying Immunologic Principles

Release Date: February 20, 2020Expiration Date: February 19, 2021 PROGRAM...

IJMSC: Perspectives of People with Multiple Sclerosis About Helminth Immunotherapy

Release Date: February 1, 2020Valid for Credit Through: February 1,...

Multiple Sclerosis in the Primary Care Setting: Strategies to Improve Identification, Management, and Coordination of Care

RELEASED: January 30, 2020 EXPIRES: January 30, 2021 PROGRAM DESCRIPTION...

Counseling Women with MS in Middle Age and the Postmenopausal Years

Release Date: January 31, 2020 Valid for Credit Through: January...

Advances in Multiple Sclerosis (AIMS) Primer: Third Edition

Release Date: 6/30/2020 Expiration Date: 6/29/2021 The third edition of...

CE Opportunities